Advanced Enzyme Re-appoints Mukund Kabra as Whole Time Director
Advanced Enzyme Technologies Ltd has re-appointed Mr. Mukund Madhusudan Kabra as Whole Time Director for another term of 5 years, effective from April 01, 2027, subject to shareholder approval at the upcoming 37th AGM. The board also approved the appointment of Mr. Pradip Bhailal Shah as an Additional Director (Independent) effective from June 12, 2026, for a 5-year term, also subject to shareholder approval. The board recommended a final dividend of ₹ 1.35 per share and deferred the declaration of an interim dividend to preserve capital for strategic opportunities. Additionally, the re-appointment of M S K A & Associates LLP as Statutory Auditors for a second term was approved, along with the allotment of 49,350 Equity Shares under the ESOP scheme.
Key Highlights
- Mukund Kabra re-appointed as Whole Time Director for 5 years from April 1, 2027.
- Pradip Bhailal Shah appointed as an Additional Independent Director from June 12, 2026.
- Final dividend of ₹ 1.35 per share recommended for FY 2025-26.
- Interim dividend declaration deferred to preserve capital.
- MSKA & Associates LLP re-appointed as Statutory Auditors for a second term.
Price Impact
More from ADVENZYMES